Dr. Zuloff-Shani holds a Ph.D. in human biology and immunology from Bar-Ilan University, Israel.
Dr. Adi Zuloff-Shani has served as Chief Technologies Officer at Therapix since February 2016, bringing with her more than 15 years of experience as an R&D executive.